| 2025-11-17 |
详情>>
内部人交易：
Kihara James等共交易6笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本16918.18万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.70美元,归母净利润1.17亿美元,同比去年增长41.98%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘后发布财报
|
| 2025-09-24 |
复牌提示：
2025-09-24 06:55:13 停牌，复牌日期 2025-09-24 07:30:00
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益0.27美元,归母净利润4565.30万美元,同比去年增长-8.59%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.11美元,归母净利润1898.70万美元,同比去年增长14.69%
|
| 2025-04-25 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors named herein to hold office until the Company’s 2028 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement.
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
4.To conduct any other business properly brought before the meeting.
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-1.34美元,归母净利润-2.16亿美元,同比去年增长-28.66%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益1.37美元,归母净利润2.26亿美元,同比去年增长469.50%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.50美元,归母净利润8270.90万美元,同比去年增长177.24%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-0.26美元,归母净利润-4190.7万美元,同比去年增长71.50%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益0.30美元,归母净利润4994.40万美元,同比去年增长219.18%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益0.10美元,归母净利润1655.50万美元,同比去年增长138.48%
|
| 2024-04-26 |
股东大会：
将于2024-05-29召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors named herein to hold office until the Company’s 2027 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement.
3.To approve the Company’s 2024 Equity Incentive Plan.
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
5.To conduct any other business properly brought before the meeting.
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-0.37美元,归母净利润-6128.6万美元,同比去年增长71.62%
|
| 2023-11-03 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.65美元,归母净利润-1.07亿美元,同比去年增长38.55%
|
| 2023-05-01 |
股东大会：
将于2023-06-01召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors named herein to hold office until the Company’s 2026 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
5.To conduct any other business properly brought before the meeting.
|
| 2022-04-29 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors named herein to hold office until the Company’s 2025 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 6,000,000 shares.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
5.To conduct any other business properly brought before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-22召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors named herein to hold office until the Company’s 2024 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
4.To conduct any other business properly brought before the meeting.
|
| 2020-04-29 |
股东大会：
将于2020-06-23召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors named herein to hold office until the Company’s 2023 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s 2004 Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares.
3.To approve the Company’s non-employee director compensation policy.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020.
6.To conduct any other business properly brought before the meeting.
|
| 2019-04-30 |
股东大会：
将于2019-06-26召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors named herein to hold office until the Company’s 2022 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 8,300,000 shares.
3.To approve an amendment to the Company’s 2004 Employee Stock Purchase Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 600,000 shares.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.
6.To conduct any other business properly brought before the meeting.
|
| 2018-04-30 |
股东大会：
将于2018-06-06召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors named herein to hold office until the Company’s 2021 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 6,700,000 shares.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.
5.To conduct any other business properly brought before the meeting.
|
| 2017-04-27 |
股东大会：
将于2017-06-13召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors named herein to hold office until the 1. To elect two Class I directors named herein to hold office until the Company’s 2020 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,500,000 shares.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
5.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017.
6.To conduct any other business properly brought before the meeting.
|
| 2016-04-29 |
股东大会：
将于2016-06-10召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors named herein to hold office until the Company’s 2019 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s 2004 Employee Stock Purchase Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 400,000 shares.
3.To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016.
6.To conduct any other business properly brought before the meeting.
|